New data shows widespread undetected metabolic risk – even among “healthy” individuals – as Noom enables members to test, ...

Hims & Hers Health (NYSE:HIMS) has launched Labs AI, an AI care agent that provides users with personalized, clinically vetted interpretations of their lab results. The company is also expanding into ...

Weight loss company Noom is offering an at-home biomarker testing kit for its U.S. members, expanding its platform into ...

For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 receptor agonists like semaglutide and tirzepatide. Now, a phase 2 clinical ...

Biochemist Svetlana Mojsov, PhD, has been awarded the Frontiers of Knowledge Award in Biology and Biomedicine, presented by Spain’s BBVA Foundation, for her collaborative research with Daniel Drucker, ...

Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...

Please note that the posts on The Blogs are contributed by third parties. The opinions, facts and any media content in them are presented solely by the authors, and neither The Times of Israel nor its ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Hims & Hers Health ...